What is the Purpose of this Study?
The purpose of this study is to evaluate the use of a magnetic resonance imaging (MRI) technique called whole-body MRI, combined with a computer program, in children and adolescents (5-18 years old) with neurofibromatosis type 1 (NF-1). The whole-body MRI with computer program is a technique that looks head-to-knee for suspicious tumors and can be completed more quickly than the standard MRI, even with patient movement. Individuals with NF-1 are recommended to have one whole-body MRI between 16-20 years old. Researchers aim to determine whether it is feasible to complete whole-body MRIs, using this novel technique paired with the computer program, to predict cancerous and non-cancerous tumors in young patients affected by NF-1.
Eligibility
- Between the ages of 5 and <18 years at the start of study. If subject will turn 18 during the study, they will be allowed to enroll.
- Clinically or molecularly confirmed diagnosis of NF-1. Subjects with mosaic/segmental NF-1 also qualify for the study.
Where can I participate?
Cedars-Sinai Cancer at SOCC
More about this Clinical Trial
What is the full name of this clinical trial?
IIT2020-23-Baca-MRINF1: Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence ^*